Is CELV or MRK a better dividend investment in 2026?

CELV currently yields 2702.70% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: CELV offers higher current income.

What is the dividend yield difference between CELV and MRK?

CELV has a forward dividend yield of 2702.70% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 2699.45 percentage points.

Home › Compare › CELV vs MRK

CELV vs MRK: Dividend Comparison 2026

CELV yields 2702.70% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CELV wins by $168570241980.86M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CELV

● Live price

2702.70%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$168570241980.89M

Annual income

$157,133,353,653,999,200.00

Full CELV calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — CELV vs MRK

📍 CELV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CELV	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CELV + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CELV pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CELV

Annual income on $10K today (after 15% tax)

$229,729.73/yr

After 10yr DRIP, annual income (after tax)

$133,563,350,605,899,310.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, CELV beats the other by $133,563,350,605,898,510.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CELV + MRK for your $10,000?

CELV: 50%MRK: 50%

100% MRK50/50100% CELV

Portfolio after 10yr

$84285120990.46M

Annual income

$78,566,676,827,000,080.00/yr

Blended yield

93.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CELV

No analyst data

Altman Z

-135.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CELV buys

MRK buys

No recent congressional trades found for CELV or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCELVMRK

Forward yield	2702.70% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$168570241980.89M ✓	$30.7K
Annual income after 10y	$157,133,353,653,999,200.00 ✓	$950.29
Total dividends collected	$167774873072.67M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CELV vs MRK ($10,000, DRIP)

Year	CELV Portfolio	CELV Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$280,970	$270,270.27	$11,192	$351.54	+$269.8K → CELV
2	$7,397,639	$7,097,001.02	$12,524	$392.70	+$7.39M → CELV
3	$182,547,490	$174,632,015.69	$14,015	$438.65	+$182.53M → CELV
4	$4,222,707,658	$4,027,381,844.00	$15,682	$489.96	+$4222.69M → CELV
5	$91,585,417,575	$87,067,120,381.11	$17,547	$547.23	+$91585.40M → CELV
6	$1,862,837,936,624	$1,764,841,539,818.28	$19,632	$611.16	+$1862837.92M → CELV
7	$35,541,549,384,067	$33,548,312,791,879.66	$21,963	$682.53	+$35541549.36M → CELV
8	$636,231,909,330,306	$598,202,451,489,354.80	$24,571	$762.18	+$636231909.31M → CELV
9	$10,688,680,679,335,756	$10,007,912,536,352,330.00	$27,486	$851.08	+$10688680679.31M → CELV
10	$168,570,241,980,888,450	$157,133,353,653,999,200.00	$30,745	$950.29	+$168570241980.86M → CELV

CELV vs MRK: Complete Analysis 2026

CELV — Stock

Cellev8 Nutrition, Inc. offers unique children's education and online games designed to help combat childhood obesity and promote making good nutritional choices. The company was founded by Michael A. Ferraro on March 19, 1999 and is headquartered in Wellington, FL.

Full CELV Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this CELV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CELV vs SCHD CELV vs JEPI CELV vs O CELV vs KO CELV vs MAIN CELV vs JNJ CELV vs ABBV CELV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.